Skip to main content
. 2007 May 1;6:3. doi: 10.1186/1476-5926-6-3

Figure 1.

Figure 1

Time course of albumin, HBV-DNA, and ALT levels in lamivudine treatment. The average serum levels of albumin (closed circles), HBV-DNA (open squares), and ALT (open circles) at 3-month intervals from the start of lamivudine therapy are plotted. Soon after the start of treatment, serum albumin levels increased rapidly and simultaneously with a decrease in HBV-DNA and serum ALT levels. The data represent mean + SD (a, b; p < 0.05 and p < 0.01 vs. 0 month, respectively).